DSM Biomedical
DSM Biomedical
DSM Biomedical, part of the global life sciences and materials sciences company Royal DSM N.V.(NYSE Euronext: DSM KON), turned to Kwittken & Company in June 2009 to raise awareness of its brand through a national media relations campaign. Although the company has one of the strongest records of biomaterials innovations and advancements, and a renowned portfolio of polymer technologies, recognition of the brand among large device and pharmaceutical companies wasn’t in line with its record of technical achievement. To effectively communicate the company’s status as a nimble innovator of materials-based technologies that enable new and more effective solutions for the medical device and biopharmaceutical industries, DSM Biomedical required an agency with a strong, technical understanding of these industries as well as solid expertise in corporate and B2B communications.
Following a competitive pitch, DSM Biomedical selected Kwittken & Company and charged the agency with advancing the company’s profile among key industry and media influencers through a variety of communications tactics, including national business and trade media relations, executive visibility management, as well as online media communications. During the first six months of its working relationship with DSM, Kwittken & Company successfully secured numerous interviews with leading trade publications, such as American Chemistry, Nursing Standard, and Drug Delivery Technology, to name a few, in addition to several bylined articles in outlets including Drug Delivery Technology, Future Materials, OrthoWorld’s BoneZone, Medical Device Technology and Medical Design Magazine.
Media Placements
MedTech Insider
Drug Delivery Technology
Bone Zone
